Octaplas is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Octapharma Usa Inc. The primary component is Plasma Protein Fraction (human).
Product ID | 68982-954_60214da1-41ca-3fb0-d605-17b8509ec9cd |
NDC | 68982-954 |
Product Type | Plasma Derivative |
Proprietary Name | Octaplas |
Generic Name | Human Plasma Proteins |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2013-07-18 |
Marketing Category | BLA / BLA |
Application Number | BLA125416 |
Labeler Name | Octapharma USA Inc |
Substance Name | PLASMA PROTEIN FRACTION (HUMAN) |
Active Ingredient Strength | 12 g/200mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2013-07-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125416 |
Product Type | LOT DISTRIBUTION DATA |
Billing Unit | ML |
Marketing Start Date | 2013-07-18 |
NDC | Brand Name | Generic Name |
---|---|---|
68982-952 | Octaplas | human plasma proteins |
68982-953 | Octaplas | human plasma proteins |
68982-954 | Octaplas | human plasma proteins |
68982-955 | Octaplas | human plasma proteins |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OCTAPLAS 79135011 not registered Dead/Abandoned |
Octapharma AG 2013-07-24 |
OCTAPLAS 79130213 4523891 Live/Registered |
Octapharma AG 2012-07-04 |